Survival after myocardial infarction according to left ventricular function and heart failure symptoms

Jarle Jortveit1, Peder L Myhre2,3, Kristian Berge3,4

  • 1Department of Cardiology, Sorlandet Hospital, Arendal, Norway.

ESC Heart Failure
|March 18, 2025
PubMed

Insights

Patients with reduced left ventricular ejection fraction (LVEF) after acute myocardial infarction (AMI) face higher mortality. Heart failure symptoms at discharge significantly increase mortality risk, especially in those with preserved LVEF.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Left ventricular (LV) dysfunction is a common complication post-acute myocardial infarction (AMI), even without overt heart failure (HF) symptoms.
  • Previous trials suggest low event rates in post-AMI LV dysfunction, necessitating real-world outcome assessment.

Purpose of the Study:

  • To evaluate the real-world prevalence and outcomes of patients post-AMI.
  • To stratify outcomes based on left ventricular ejection fraction (LVEF) and the presence of HF symptoms.

Main Methods:

  • A cohort study utilizing data from the Norwegian Myocardial Infarction Registry (2013-2022).
  • Analysis included short- and long-term all-cause mortality using Kaplan-Meier curves, Life Table, and Cox regression models.

Main Results:

  • Among 70,809 AMI patients, 13.3% had reduced LVEF (≤40%), with 63.2% symptomatic for HF.
  • 1-year mortality rates varied significantly by LVEF and HF symptoms, reaching 20.2% in symptomatic patients with reduced LVEF.
  • Symptomatic patients had a higher mortality risk (adjusted HR 1.15-1.85) compared to asymptomatic individuals across LVEF categories.

Conclusions:

  • Reduced LVEF post-AMI is linked to substantial 1-year mortality, exceeding rates seen in recent trials.
  • Heart failure symptoms during hospitalization worsen outcomes, particularly for patients with preserved LVEF, but add less risk to those with already reduced LVEF.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
299
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
280
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
683